Idaho Bills

Adds to existing law to establish a moratorium on certain uses of human gene therapy products.

This legislation, titled the "Doug Cameron Act" ensures a moratorium on the administration by any route or modality of any gene therapy product for any infectious disease indication, whether or not formally described as a vaccine immunization, and whether or not they meet the definition of "vaccine" under Idaho State Statute 41-6002(8).

Adds to existing law to establish provisions regarding limitation of distribution and waiver of immunity for certain human gene therapy products.

The purpose of this legislation is to ensure accountability in the distribution and administration of human gene therapy products for infectious disease indications in Idaho. Given the unique nature of these products which mayhavelong-termandunforeseenconsequences–thisbillestablishesthatmanufacturersmustacceptfulllegal responsibility for design defects in their products if they choose to distribute them in the state. Under current federal law, certain vaccine manufacturers are shielded from liability for design defects through the National Childhood Vaccine Injury Act (42 U.S.C. 300aa-1, et seq.). This bill removes such immunity for human gene therapy products distributed in Idaho, ensuring that manufactures remain legally accountable for potential design defects. By requiring an affirmative waiver of immunity, this legislation prioritizes the rights of Idaho citizens to seek redress for injuries potentially caused by potentially defective human gene therapy products. It also serves as a safeguard against the unchecked proliferation of genetic medical interventions that have not been subjected to adequate long-term study.